{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:18:57Z","timestamp":1791555537480,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bagenkop Nielsens \u00d8jen-Fond"},{"name":"Fight for Sight, Denmark"},{"name":"The Danish Research Foundation"},{"DOI":"10.13039\/501100008248","name":"Fonden for Faglig Udvikling af Speciall\u00e6gepraksis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019562","name":"Synoptik-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019562","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danish Regions"},{"DOI":"10.13039\/501100008218","name":"Gangstedfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller Fonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40123-024-01051-5","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T12:03:40Z","timestamp":1729253020000},"page":"3111-3122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Macular Choroidal Thickness in Danish Children with Myopia After Two-Year Low-Dose Atropine and One-Year Wash-Out: A Placebo-Controlled, Randomized Clinical Trial"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1092-4736","authenticated-orcid":false,"given":"Niklas C.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-0217","authenticated-orcid":false,"given":"Anders","family":"Hvid-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2534","authenticated-orcid":false,"given":"Toke","family":"Bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-2171","authenticated-orcid":false,"given":"Flemming","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9979-3082","authenticated-orcid":false,"given":"Nina","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-1510","authenticated-orcid":false,"given":"Line","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"2","key":"1051_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29(2):144\u201368.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"1051_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.64.6.4","volume":"64","author":"LA Ostrin","year":"2023","unstructured":"Ostrin LA, Harb E, Nickla DL, et al. IMI\u2014The dynamic choroid: new insights, challenges, and potential significance for human myopia. Investig Ophthalmol Vis Sci. 2023;64(6):4.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"1051_CR3","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1167\/iovs.11-8383","volume":"53","author":"S Usui","year":"2012","unstructured":"Usui S, Ikuno Y, Akiba M, et al. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012;53(4):2300\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1051_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1159\/000511201","volume":"64","author":"G Insa-S\u00e1nchez","year":"2021","unstructured":"Insa-S\u00e1nchez G, Fuentes-Broto L, Cobos A, et al. Choroidal thickness and volume modifications induced by aerobic exercise in healthy young adults. Ophthalmic Res. 2021;64(4):604\u201312.","journal-title":"Ophthalmic Res"},{"issue":"11","key":"1051_CR5","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1167\/iovs.15-17102","volume":"56","author":"EC Woodman-Pieterse","year":"2015","unstructured":"Woodman-Pieterse EC, Read SA, Collins MJ, Alonso-Caneiro D. Regional changes in choroidal thickness associated with accommodation. Invest Ophthalmol Vis Sci. 2015;56(11):6414\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1051_CR6","first-page":"5","volume":"9","author":"M Xu","year":"2022","unstructured":"Xu M, Yu X, Wan M, et al. Two-year longitudinal change in choroidal and retinal thickness in school-aged myopic children: exploratory analysis of clinical trials for myopia progression. Eye Vis (London, England). 2022;9(1):5.","journal-title":"Eye Vis (London, England)"},{"issue":"1","key":"1051_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/OPX.0000000000001973","volume":"100","author":"E Kobia-Acquah","year":"2023","unstructured":"Kobia-Acquah E, Flitcroft DI, Lingham G, Paudel N, Loughman J. Choroidal thickness profiles and associated factors in myopic children. Optom Vis Sci. 2023;100(1):57\u201366.","journal-title":"Optom Vis Sci"},{"issue":"5","key":"1051_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.5.5","volume":"62","author":"K Ohno-Matsui","year":"2021","unstructured":"Ohno-Matsui K, Wu PC, Yamashiro K, et al. IMI pathologic myopia. Invest Ophthalmol Vis Sci. 2021;62(5):5.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1051_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.18240\/ijo.2023.03.17","volume":"16","author":"QY Meng","year":"2023","unstructured":"Meng QY, Miao ZQ, Liang ST, et al. Choroidal thickness, myopia, and myopia control interventions in children: a Meta-analysis and systemic review. Int J Ophthalmol. 2023;16(3):453\u201364.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"1051_CR10","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.13866","volume":"97","author":"Z Li","year":"2019","unstructured":"Li Z, Hu Y, Cui D, et al. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length. Acta Ophthalmol. 2019;97(3):e454\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1051_CR11","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/OPX.0000000000000894","volume":"93","author":"Z Chen","year":"2016","unstructured":"Chen Z, Xue F, Zhou J, Qu X, Zhou X. Effects of orthokeratology on choroidal thickness and axial length. Optom Vis Sci Off Publ Am Acad Optom. 2016;93(9):1064\u201371.","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"issue":"September","key":"1051_CR12","first-page":"1","volume":"6","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Zhou Y, Xie Z, et al. The effect of topical atropine on the choroidal thickness of healthy children. Sci Rep. 2016;6(September):1\u20138.","journal-title":"Sci Rep"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","volume":"237","author":"JC Yam","year":"2022","unstructured":"Yam JC, Jiang Y, Lee J, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study. Am J Ophthalmol. 2022;237:130\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1051_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000526448","volume":"66","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhu Y, Huang XB, et al. Changes of choroidal thickness in children after short-term application of 1% atropine gel. Ophthalmic Res. 2023;66(1):421\u201330.","journal-title":"Ophthalmic Res"},{"issue":"3","key":"1051_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/opo.12052","volume":"33","author":"NA McBrien","year":"2013","unstructured":"McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt. 2013;33(3):373\u20138.","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt"},{"key":"1051_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115542","volume":"167","author":"K Thomson","year":"2023","unstructured":"Thomson K, Karouta C, Weber D, et al. The role of the serotonergic system in atropine\u2019s anti-myopic effects. Biomed Pharmacother. 2023;167: 115542.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1051_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2 myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"1051_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, et al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129(3):308\u201321.","journal-title":"Ophthalmology"},{"issue":"9","key":"1051_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jfo.2020.04.023","volume":"43","author":"W Li","year":"2020","unstructured":"Li W, Jiang R, Zhu Y, Zhou J, Cui C. Effect of 0.01% atropine eye drops on choroidal thickness in myopic children. J Fr Ophtalmol. 2020;43(9):862\u20138.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1051_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40123-022-00476-0","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu X, Xuan Y, et al. Short-term effects of atropine 0.01% on the structure and vasculature of the choroid and retina in myopic Chinese children. Ophthalmol Ther. 2022;11(2):833\u201356. https:\/\/doi.org\/10.1007\/s40123-022-00476-0.","journal-title":"Ophthalmol Ther"},{"issue":"14","key":"1051_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.61.14.1","volume":"61","author":"L Ye","year":"2020","unstructured":"Ye L, Shi Y, Yin Y, et al. Effects of atropine treatment on choroidal thickness in myopic children. Investig Ophthalmol Vis Sci. 2020;61(14):1\u201310.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"1051_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.65.5.25","volume":"65","author":"F Yii","year":"2024","unstructured":"Yii F, Bernabeu MO, Dhillon B, Strang N, MacGillivray T. Retinal changes from hyperopia to myopia: not all diopters are created equal. Invest Ophthalmol Vis Sci. 2024;65(5):25.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1051_CR23","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1167\/iovs.17-22748","volume":"59","author":"J Deng","year":"2018","unstructured":"Deng J, Li X, Jin J, et al. Distribution pattern of choroidal thickness at the posterior pole in Chinese children with myopia. Investig Ophthalmol Vis Sci. 2018;59(3):1577\u201386.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"1051_CR24","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","volume":"41","author":"Q Hao","year":"2021","unstructured":"Hao Q, Zhao Q. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination. Int Ophthalmol. 2021;41(9):2963\u201371. https:\/\/doi.org\/10.1007\/s10792-021-01855-5.","journal-title":"Int Ophthalmol"},{"key":"1051_CR25","first-page":"280","volume":"2023","author":"E Kobia-Acquah","year":"2023","unstructured":"Kobia-Acquah E, Flitcroft DI, Lingham G, Kerin E, Loughman J. Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children. Ophthalmic Physiol Opt. 2023;2023:280\u201391.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"1051_CR26","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","volume":"41","author":"L Joachimsen","year":"2021","unstructured":"Joachimsen L, Farassat N, Bleul T, et al. Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study. Int Ophthalmol. 2021;41(6):2001\u20138.","journal-title":"Int Ophthalmol"},{"issue":"13","key":"1051_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.61.13.1","volume":"61","author":"TQ Luong","year":"2020","unstructured":"Luong TQ, Shu YH, Modjtahedi BS, et al. Racial and ethnic differences in myopia progression in a large, diverse cohort of pediatric patients. Investig Ophthalmol Vis Sci. 2020;61(13):1\u20138.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"1051_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12886-023-03177-9","volume":"23","author":"NC Hansen","year":"2023","unstructured":"Hansen NC, Hvid-Hansen A, M\u00f8ller F, et al. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety. BMC Ophthalmol. 2023;23(1):438.","journal-title":"BMC Ophthalmol"},{"key":"1051_CR29","first-page":"1","volume":"200","author":"H Jensen","year":"1991","unstructured":"Jensen H. Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops. Acta Ophthalmol Suppl (Oxf). 1991;200:1\u201379.","journal-title":"Acta Ophthalmol Suppl (Oxf)"},{"key":"1051_CR30","unstructured":"R Core Team. R: a language and environment for statistical computing. 2021"},{"key":"1051_CR31","doi-asserted-by":"crossref","unstructured":"Ozenne B, Forman J. LMMstar: Repeated measurement models for discrete times. R package version 0.3.2. 2021.","DOI":"10.32614\/CRAN.package.LMMstar"},{"issue":"1","key":"1051_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"issue":"3","key":"1051_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.65.3.1","volume":"65","author":"M Shen","year":"2024","unstructured":"Shen M, Han X, Yang Y, et al. Longitudinal changes in choroidal thickness varied with refractive progression in myopic and non-myopic children: a two-year cohort study. Investig Ophthalmol Vis Sci. 2024;65(3):1\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1051_CR34","doi-asserted-by":"crossref","unstructured":"Read SA, Alonso-caneiro D, Vincent SJ, et al. Longitudinal changes in choroidal thickness and eye growth in childhood science, Queensland University of Technology, Brisbane, Queensland, Australia Corresponding author\u202f: Dr Scott Read Contact Lens and Visual Optics Laboratory School of Optometry an. 2015","DOI":"10.1167\/iovs.15-16446"},{"issue":"12","key":"1051_CR35","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1167\/iovs.19-26807","volume":"60","author":"MH Hansen","year":"2019","unstructured":"Hansen MH, Li XQ, Larsen M, et al. Five-year change in choroidal thickness in relation to body development and axial eye elongation: the CCC2000 eye study. Investig Ophthalmol Vis Sci. 2019;60(12):3930\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"1051_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3341\/kjo.2012.26.4.255","volume":"26","author":"JW Shin","year":"2012","unstructured":"Shin JW, Shin YU, Cho HY, Lee BR. Measurement of choroidal thickness in normal eyes using 3D OCT-1000 spectral domain optical coherence tomography. Korean J Ophthalmol. 2012;26(4):255\u20139.","journal-title":"Korean J Ophthalmol"},{"issue":"10","key":"1051_CR37","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.1167\/iovs.13-12350","volume":"54","author":"T Nagasawa","year":"2013","unstructured":"Nagasawa T, Mitamura Y, Katome T, et al. Macular choroidal thickness and volume in healthy pediatric individuals measured by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(10):7068\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1051_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241759","volume":"15","author":"PK Verkicharla","year":"2020","unstructured":"Verkicharla PK, Kammari P, Das AV. Myopia progression varies with age and severity of myopia. PLoS ONE. 2020;15(11): e0241759. https:\/\/doi.org\/10.1371\/journal.pone.0241759.","journal-title":"PLoS ONE"},{"issue":"6","key":"1051_CR39","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","volume":"48","author":"DO Mutti","year":"2007","unstructured":"Mutti DO, Hayes JR, Mitchell GL, et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Investig Ophthalmol Vis Sci. 2007;48(6):2510\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"30","key":"1051_CR40","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","volume":"115","author":"H Wu","year":"2018","unstructured":"Wu H, Chen W, Zhao F, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci U S A. 2018;115(30):E7091\u2013100.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1051_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40662-021-00269-9","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X, Lin Z, Wang F, et al. Choroidal thickness and choriocapillaris vascular density in myopic anisometropia. Eye Vis. 2021;8(1):1\u201310. https:\/\/doi.org\/10.1186\/s40662-021-00269-9.","journal-title":"Eye Vis"},{"issue":"3","key":"1051_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/02713683.2021.2006236","volume":"47","author":"L Liu","year":"2022","unstructured":"Liu L, Zhu C, Yuan Y, et al. Three-dimensional choroidal vascularity index in high myopia using swept-source optical coherence tomography. Curr Eye Res. 2022;47(3):484\u201392. https:\/\/doi.org\/10.1080\/02713683.2021.2006236.","journal-title":"Curr Eye Res"},{"issue":"8","key":"1051_CR43","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1167\/iovs.18-26397","volume":"60","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhang G, Zhou X, et al. Changes in choroidal thickness and choroidal blood perfusion in guinea pig myopia. Invest Ophthalmol Vis Sci. 2019;60(8):3074\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1051_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/tjo.TJO-D-24-00027","volume":"14","author":"JTW Au Eong","year":"2024","unstructured":"Au Eong JTW, Chen KS, Teo BHK, Lee SSY, Au Eong KG. Impact of the coronavirus disease 2019 pandemic on the progression, prevalence, and incidence of myopia: a systematic review. Taiwan J Ophthalmol. 2024;14(2):159\u201371.","journal-title":"Taiwan J Ophthalmol"}],"updated-by":[{"DOI":"10.1007\/s40123-025-01154-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000}}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01051-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01051-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:21:58Z","timestamp":1747646518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01051-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01051-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40123-025-01154-7","asserted-by":"object"}]},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to incorrect figure 2. Now, it has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40123-025-01154-7","URL":"https:\/\/doi.org\/10.1007\/s40123-025-01154-7","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Niklas C Hansen, Anders Hvid-Hansen, Toke Bek, Flemming M\u00f8ller, Nina Jacobsen, and Line Kessel declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This trial was approved by the Committees on Health Research Ethics in the Capital Region of Denmark (reference number: H-18043987), the Danish Medicines Agency (reference number: 2018040088), and the Danish Data Protection Agency via the Capital Region of Denmark (reference: P-2022\u201385). The trial followed the Declaration of Helsinki. All parents of the study participants provided written informed consent and study participants consented verbally.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}